129 related articles for article (PubMed ID: 9533897)
21. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines.
Rochford R; Cannon MJ; Sabbe RE; Adusumilli K; Picchio G; Glynn JM; Noonan DJ; Mosier DE; Hobbs MV
Viral Immunol; 1997; 10(4):183-95. PubMed ID: 9473149
[TBL] [Abstract][Full Text] [Related]
22. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
Jochems GJ; Bende RJ; Klein MR; Zeijlemaker WP; van Lier RA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):124-33. PubMed ID: 8395233
[TBL] [Abstract][Full Text] [Related]
23. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
24. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
25. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction.
Yang L; Aozasa K; Oshimi K; Takada K
Cancer Res; 2004 Aug; 64(15):5332-7. PubMed ID: 15289339
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
28. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 expression induced by Epstein-Barr virus-infected cells.
Yao L; Setsuda J; Sgadari C; Cherney B; Tosato G
J Leukoc Biol; 2001 May; 69(5):779-84. PubMed ID: 11358987
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
31. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
Yajima M; Kanda T; Takada K
J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
[TBL] [Abstract][Full Text] [Related]
32. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
[TBL] [Abstract][Full Text] [Related]
33. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
[TBL] [Abstract][Full Text] [Related]
34. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
[TBL] [Abstract][Full Text] [Related]
35. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.
Baran-Marszak F; Laguillier C; Youlyouz I; Feuillard J; Mariette X; Fagard R; Raphaël M
Cytokine; 2006 Mar; 33(6):337-45. PubMed ID: 16713282
[TBL] [Abstract][Full Text] [Related]
36. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
Woodford NL; Call DR; Remick DG; Rochford R
Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
[TBL] [Abstract][Full Text] [Related]
37. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
38. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
Fagard R; Mouas H; Dusanter-Fourt I; Devillers C; Bissières P; Martin A; Lenoir G; VanTan H; Feuillard J; Raphaël M
Oncogene; 2002 Jul; 21(29):4473-80. PubMed ID: 12085225
[TBL] [Abstract][Full Text] [Related]
39. Lymphokine-regulated differential expression of mRNA for p75kDa-IL-2R and p55kDa-IL-2R in a cloned B lymphoma line (BLC1-CL-3 cells).
Nakanishi K; Matsui K; Hirose S; Yoshimoto T; Hiroishi K; Kono T; Hada T; Hamaoka T; Higashino K
J Immunol; 1990 Sep; 145(5):1423-9. PubMed ID: 2117031
[TBL] [Abstract][Full Text] [Related]
40. Mycoplasmas as cofactors in infection due to the human immunodeficiency virus.
Montagnier L; Blanchard A
Clin Infect Dis; 1993 Aug; 17 Suppl 1():S309-15. PubMed ID: 8399934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
